What is APOE4 and why does it matter?

APOE4 is a variant of the Apolipoprotein E gene and the strongest genetic risk factor for late-onset Alzheimer's disease. Approximately 25% of people carry at least one copy. Heterozygous carriers (e3/e4) have roughly 3x increased risk, while homozygous carriers (e4/e4) face up to 12-15x increased risk compared to the most common genotype (e3/e3).

How does the PHOENIX Community help APOE4 carriers?

The PHOENIX Community provides personalized, science-backed protocols, Phoenix AI blood work analysis, experiment tracking, accountability pods, and a supportive community specifically designed for APOE4 carriers to optimize their brain health and beat genetic odds.

Can APOE4 carriers prevent Alzheimer's disease?

While no intervention guarantees prevention, research including the FINGER trial shows that APOE4 carriers who adopt proactive multi-domain lifestyle interventions - exercise, diet, cognitive stimulation, and vascular risk management - can significantly reduce their risk and improve cognitive function. Many APOE4/4 carriers never develop Alzheimer's, especially those who take early proactive action.

What supplements should APOE4 carriers take?

Research suggests several supplements may benefit APOE4 carriers: high-dose Omega-3 fatty acids (DHA/EPA) for neuroinflammation, Vitamin D for neuroprotection, NAD+ precursors (NMN or NR) for cellular energy, Curcumin for anti-inflammatory effects, B-vitamins for homocysteine management, and Magnesium for sleep and neural function.

What diet is best for APOE4 carriers?

The Mediterranean and MIND diets have the strongest evidence for brain health in APOE4 carriers. Key principles include high consumption of leafy greens, berries, nuts, olive oil, and fatty fish; moderate whole grains and legumes; and limited saturated fats, processed foods, and refined sugars.

How much does Phoenix membership cost?

Phoenix offers two membership tiers: Ember at $39/month ($390/year) for community and peer support with accountability pods, and Core at $79/month ($790/year) for the full optimization suite including blood work analysis, experiment tracking, and Phoenix AI insights. Both plans include a 60-day money-back guarantee.

What blood biomarkers matter for APOE4 carriers?

Key biomarkers for APOE4 carriers include lipid panel (total cholesterol, LDL-P, HDL, triglycerides, Lp(a)), inflammatory markers (hs-CRP, homocysteine), metabolic markers (fasting glucose, HbA1c, fasting insulin), vitamins (D, B12, folate), and hormones (thyroid panel). Phoenix AI analyzes these in the context of APOE4-specific research.

What is APOE4 and why does it matter?

APOE4 is a variant of the Apolipoprotein E gene and the strongest genetic risk factor for late-onset Alzheimer's disease. Approximately 25% of people carry at least one copy. Heterozygous carriers (e3/e4) have roughly 3x increased risk, while homozygous carriers (e4/e4) face up to 12-15x increased risk compared to the most common genotype (e3/e3).

How does the PHOENIX Community help APOE4 carriers?

The PHOENIX Community provides personalized, science-backed protocols, Phoenix AI blood work analysis, experiment tracking, accountability pods, and a supportive community specifically designed for APOE4 carriers to optimize their brain health and beat genetic odds.

Can APOE4 carriers prevent Alzheimer's disease?

While no intervention guarantees prevention, research including the FINGER trial shows that APOE4 carriers who adopt proactive multi-domain lifestyle interventions — exercise, diet, cognitive stimulation, and vascular risk management — can significantly reduce their risk and improve cognitive function. Many APOE4/4 carriers never develop Alzheimer's, especially those who take early proactive action.

What kind of experiments and protocols are available?

Phoenix offers evidence-based experiments including targeted supplements (Omega-3 DHA/EPA, Vitamin D, NAD+ precursors, Curcumin), lifestyle interventions (Zone 2 cardiovascular training, sleep optimization, Mediterranean/MIND diet), advanced therapies (photobiomodulation, cold exposure), and cognitive practices (meditation, brain training) — all tailored for APOE4 carriers with research citations.

How does the blood work analysis work?

Members upload blood test results as PDF or enter them manually. Phoenix AI analyzes biomarkers specifically relevant to APOE4 carriers — including lipid panels, inflammatory markers (hs-CRP, homocysteine), metabolic indicators, and vitamin levels — then provides personalized recommendations and tracks changes over time.

What gene test do I need to find out my APOE status?

APOE genotyping is available through consumer genetic testing services like 23andMe (health report), clinical genetic testing ordered by your doctor, or specialized services. The test identifies which combination of APOE variants (e2, e3, or e4) you carry. Results show your genotype such as e3/e4 (heterozygous) or e4/e4 (homozygous).

What supplements should APOE4 carriers take?

Research suggests several supplements may benefit APOE4 carriers: high-dose Omega-3 fatty acids (DHA/EPA) for neuroinflammation, Vitamin D for neuroprotection, NAD+ precursors (NMN or NR) for cellular energy, Curcumin for anti-inflammatory effects, B-vitamins for homocysteine management, and Magnesium for sleep and neural function. Phoenix's experiment library provides dosing guidance and tracks effectiveness for each member.

What diet is best for APOE4 carriers?

The Mediterranean and MIND diets have the strongest evidence for brain health in APOE4 carriers. Key principles include high consumption of leafy greens, berries, nuts, olive oil, and fatty fish; moderate whole grains and legumes; and limited saturated fats, processed foods, and refined sugars. Some APOE4 carriers also benefit from time-restricted eating approaches.

What is an APOE4/4 homozygous carrier?

A homozygous APOE4/4 carrier has inherited the APOE4 variant from both parents. This is the highest genetic risk category for Alzheimer's disease, affecting approximately 2-3% of the population. While the risk is significantly elevated, it is not deterministic — many APOE4/4 carriers never develop Alzheimer's, especially those who adopt proactive health strategies early.

How much does Phoenix membership cost?

Phoenix offers two membership tiers: Ember at $39/month ($468/year, billed annually) or $47/month for community and peer support with accountability pods, and Core at $69/month ($828/year, billed annually) or $83/month for the full optimization suite including blood work analysis, experiment tracking, and Phoenix AI insights. Both plans include a 60-day money-back guarantee.

What blood biomarkers matter for APOE4 carriers?

Key biomarkers for APOE4 carriers include lipid panel (total cholesterol, LDL-P, HDL, triglycerides, Lp(a)), inflammatory markers (hs-CRP, homocysteine), metabolic markers (fasting glucose, HbA1c, fasting insulin), vitamins (D, B12, folate), and hormones (thyroid panel). Phoenix AI analyzes these in the context of APOE4-specific research to provide personalized insights.

How do Phoenix accountability pods work?

Each month, Phoenix matches members into small groups (pods) of 2-4 APOE4 carriers. Matching considers health goals, genotype (e3/e4 vs e4/e4), lifestyle factors, timezone, and personal interests. Pod members support each other through weekly check-ins, shared experiment experiences, and mutual encouragement. Pods refresh monthly to expand members' support networks.

Is the PHOENIX Community right for me?

If you're an APOE4 carrier or concerned about brain health and aging, and you're committed to taking a proactive, science-based approach to optimize your cognitive future, the PHOENIX Community provides the tools, knowledge, and support you need. Phoenix is designed for people who want to take action rather than wait.

All trials

NCT06862960PHASE2NOT YET RECRUITING

Ozanimod in Patients With Alzheimer's Disease

Eligibility check — Phoenix members

Phoenix members see for THIS trial:

APOE genotype match
Cognitive status fits inclusion
Specific exclusions flagged
Distance to nearest site

Check my eligibility — become a member

Start

2025-07-01

Interventions tested

DRUGOzanimod
DRUGConventional medication

View full record on ClinicalTrials.gov